Patent · US Active

Class II, type II CRISPR systems

US11946039B2 · kind B2 · utility

1Cited by
7References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 5, 2022
Grant dateApr 2, 2024
Priority date—
Expiry dateJul 5, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/20
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides for endonuclease enzymes as well as methods of using such enzymes or variants thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.